BR0107730A - Inalador aerosol - Google Patents

Inalador aerosol

Info

Publication number
BR0107730A
BR0107730A BR0107730-9A BR0107730A BR0107730A BR 0107730 A BR0107730 A BR 0107730A BR 0107730 A BR0107730 A BR 0107730A BR 0107730 A BR0107730 A BR 0107730A
Authority
BR
Brazil
Prior art keywords
aerosol inhaler
hydrofluoralkane
propellant
solvent
optionally
Prior art date
Application number
BR0107730-9A
Other languages
English (en)
Other versions
BR0107730B1 (pt
Inventor
Gaetano Brambilla
Isabella Panza
Alessandra Ferraris
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11443627&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0107730(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of BR0107730A publication Critical patent/BR0107730A/pt
Publication of BR0107730B1 publication Critical patent/BR0107730B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0086—Inhalation chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00—Characteristics of a physical parameter; associated device therefor
    • A61M2206/10—Flow characteristics
    • A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Nozzles (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"INALADOR AEROSOL". Um dispositivo para aplicação de aerossóis dosimetrados compostos de um princípio ativo em solução em um propelente de hidrofluoralcano, um co-solvente e, opcionalmente, um componente de baixa volatilidade.
BRPI0107730-9A 2000-01-07 2001-01-02 inalador aerosol. BR0107730B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI000010A IT1317720B1 (it) 2000-01-07 2000-01-07 Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
PCT/EP2001/000002 WO2001049350A1 (en) 2000-01-07 2001-01-02 Aerosol inhaler

Publications (2)

Publication Number Publication Date
BR0107730A true BR0107730A (pt) 2003-02-25
BR0107730B1 BR0107730B1 (pt) 2009-05-05

Family

ID=11443627

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0107730-9A BR0107730B1 (pt) 2000-01-07 2001-01-02 inalador aerosol.

Country Status (23)

Country Link
US (1) US20050034720A1 (pt)
EP (1) EP1244487B1 (pt)
AT (1) ATE342081T1 (pt)
AU (1) AU2512801A (pt)
BR (1) BR0107730B1 (pt)
CA (1) CA2396273C (pt)
CZ (1) CZ303394B6 (pt)
DE (1) DE60123746T2 (pt)
DK (1) DK1244487T3 (pt)
DZ (1) DZ3243A1 (pt)
EG (1) EG22790A (pt)
ES (1) ES2273800T3 (pt)
HU (1) HU229516B1 (pt)
IT (1) IT1317720B1 (pt)
JO (1) JO2506B1 (pt)
MA (1) MA26392A1 (pt)
PL (1) PL198683B1 (pt)
PT (1) PT1244487E (pt)
SA (1) SA01210645B1 (pt)
SI (1) SI1244487T1 (pt)
SK (1) SK286139B6 (pt)
TN (1) TNSN01003A1 (pt)
WO (1) WO2001049350A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
AU2002340083A1 (en) * 2001-09-28 2003-04-07 Kurve Technology, Inc Nasal nebulizer
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
US8122881B2 (en) 2002-05-09 2012-02-28 Kurve Technology, Inc. Particle dispersion device for nasal delivery
US20070095342A1 (en) * 2005-10-18 2007-05-03 Bijan Olfati Accessorized inhaler
US7905229B2 (en) 2006-08-30 2011-03-15 Kurve Technology, Inc. Aerosol generating and delivery device
BRPI0603695A (pt) * 2006-09-13 2008-04-29 Cesar Eduardo Marques Da Silva aerocámara para aplicação de medicamentos aerossol com válvula geométrica
EP2534958A1 (en) 2007-12-14 2012-12-19 AeroDesigns, Inc Delivering aerosolizable food products
EP2080507A1 (en) 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Pharmaceutical formulations comprising an anticholinergic drug
BR112012007484A2 (pt) 2009-10-02 2020-06-09 Chiesi Farm Spa formulações aerossóis farmacêuticas de formoterol e dipropionato de beclometasona
EP3020393B1 (en) * 2009-12-16 2020-10-07 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
DK2515854T3 (da) 2009-12-23 2014-05-26 Chiesi Farma Spa Aerosolformulering for COPD
KR101738712B1 (ko) 2009-12-23 2017-05-22 키에시 파르마슈티시 엣스. 피. 에이. Ｃｏｐｄ용 조합요법
KR20120106753A (ko) 2009-12-23 2012-09-26 키에시 파르마슈티시 엣스. 피. 에이. Ｃｏｐｄ용 에어로졸 제제
DK2515855T6 (da) 2009-12-23 2023-06-06 Chiesi Farm Spa Kombinationsterapi til COPD
US9603906B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Inhalable liquid formulations of DNase I
TN2016000261A1 (en) 2013-12-30 2017-10-06 Chiesi Farm Spa Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination.
US10098837B2 (en) 2016-07-28 2018-10-16 Chiesi Farmaceutici S.P.A. Combination therapy for COPD

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) * 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
US3622053A (en) * 1969-12-10 1971-11-23 Schering Corp Aerosol inhaler with flip-up nozzle
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US4584320A (en) * 1985-01-03 1986-04-22 David Rubin Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
IT1244441B (it) * 1990-09-13 1994-07-15 Chiesi Farma Spa Dispositivo per l'inalazione boccale di farmaci aerosol
US6006745A (en) * 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
EP0585379B1 (en) * 1991-05-21 1998-09-30 Abbott Laboratories Aerosol inhalation device
CZ282972B6 (cs) * 1991-08-29 1997-11-12 Broncho-Air Medizintechnik Ag Lékařský přístroj pro inhalování dávkovaných aerosolů
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
WO1994013263A1 (en) * 1992-12-09 1994-06-23 Jager Paul D Stabilized medicinal aerosol solution formulations
SE9203743D0 (sv) * 1992-12-11 1992-12-11 Astra Ab Efficient use
US5899201A (en) * 1993-05-26 1999-05-04 Minnesota Mining And Manufacturing Company Aerosol actuator
GB9311892D0 (en) * 1993-06-09 1993-07-28 Glaxo Wellcome Australia Ltd Device
DK0735884T3 (da) * 1993-12-20 2000-10-09 Minnesota Mining & Mfg Flunisolid-aerosolformuleringer
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
ES2276736T3 (es) * 1995-04-14 2007-07-01 Smithkline Beecham Corporation Inhalador medidor de dosis para propionato de flucticasona.
KR19980703850A (ko) * 1995-04-14 1998-12-05 그레이엄브레레톤 베클로메타손 디프로피오네이트용 계량 흡입기
SI0820279T1 (en) * 1995-04-14 2002-12-31 Smithkline Beecham Corporation Metered dose inhaler for albuterol
EP0820323B1 (en) * 1995-04-14 2003-09-24 SmithKline Beecham Corporation Metered dose inhaler for salmeterol
WO1998003533A1 (en) 1996-07-24 1998-01-29 Oligos Etc. And Oligos Therapeutics, Inc. Antisense oligonucleotides as antibacterial agents
US6413496B1 (en) * 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
AU718967B2 (en) * 1997-02-05 2000-05-04 Jagotec Ag Medical aerosol formulations
US6193954B1 (en) * 1997-03-21 2001-02-27 Abbott Laboratories Formulations for pulmonary delivery of dopamine agonists
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
BR7702049U (pt) * 1997-09-05 1999-09-14 Chiesi Farma Spa Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
NZ504021A (en) * 1997-10-17 2003-04-29 Systemic Pulmonary Delivery Lt Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6045784A (en) * 1998-05-07 2000-04-04 The Procter & Gamble Company Aerosol package compositions containing fluorinated hydrocarbon propellants
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
JP2000112547A (ja) * 1998-10-05 2000-04-21 Mitsubishi Electric Corp 基板電圧発生回路および半導体集積回路装置
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
CZ303154B6 (cs) * 1998-11-13 2012-05-09 Jagotec Ag Suchá prášková formulace k inhalaci obsahující stearát horecnatý
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6290930B1 (en) * 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
EP1143930B8 (en) * 1999-09-11 2008-03-19 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
CZ303833B6 (cs) * 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
DE60103527T2 (de) * 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
US6616193B2 (en) * 2001-10-03 2003-09-09 Kool, L.L.C. Ventilating system connector assembly and method of use
MXPA04008372A (es) * 2002-03-01 2004-11-26 Chiesi Farma Spa Formulacion superfina de formoterol.
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"

Also Published As

Publication number Publication date
CZ303394B6 (cs) 2012-08-29
CA2396273C (en) 2009-11-17
ITMI20000010A0 (it) 2000-01-07
DE60123746D1 (de) 2006-11-23
PL356849A1 (en) 2004-07-12
SI1244487T1 (sl) 2007-04-30
SK9482002A3 (en) 2002-10-08
WO2001049350A1 (en) 2001-07-12
ES2273800T3 (es) 2007-05-16
AU2512801A (en) 2001-07-16
BR0107730B1 (pt) 2009-05-05
EP1244487B1 (en) 2006-10-11
IT1317720B1 (it) 2003-07-15
DZ3243A1 (fr) 2001-07-12
JO2506B1 (en) 2009-10-05
SA01210645B1 (ar) 2007-07-31
PL198683B1 (pl) 2008-07-31
DE60123746T2 (de) 2007-10-11
CZ20022331A3 (cs) 2002-11-13
SK286139B6 (sk) 2008-04-07
HUP0300405A3 (en) 2003-07-28
DK1244487T3 (da) 2007-02-19
US20050034720A1 (en) 2005-02-17
PT1244487E (pt) 2007-01-31
EG22790A (en) 2003-08-31
ATE342081T1 (de) 2006-11-15
EP1244487A1 (en) 2002-10-02
HUP0300405A2 (hu) 2003-06-28
ITMI20000010A1 (it) 2001-07-07
HU229516B1 (en) 2014-01-28
TNSN01003A1 (fr) 2003-04-03
MA26392A1 (fr) 2004-12-01
CA2396273A1 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
BR0107730A (pt) Inalador aerosol
DK1257254T3 (da) Formuleringer indeholdende et anticholinergt lægemiddel til behandling af kronisk obstruktiv lungesygdom
CO4940408A1 (es) Composicion de aerosol farmaceutico
NO972681L (no) Aerosol legemiddel formuleringer
EE04608B1 (et) Seade aerosooli kujul toimeaine kohaletoimetamisejuhtimiseks ja meetod aerosooli kujul toimeaine kohaletoimetamiseks
LTPA2011011I1 (lt) Stabilūs farmacinių tirpalų preparatai, skirti slėginiams dozuotiems inhaliatoriams
TR199701169T1 (xx) Salmeterol i�in �l��lm�� doz inhaleri.
DE60129849D1 (de) Bioadhäsiver schaumstoffilm mit hinhaltender wirkstoffreigabe
DE60232178D1 (de) Vorrichtung zur topischen verabreichung
DK1265665T3 (da) Indåndingsaktiveret indretning
PT1123120E (pt) Formulacao medicinal em aerossol
BR9917089A (pt) Composições e métodos para distribuição mucosal
NO20030133L (no) Ny aerosolformulering inneholdende et polart fluorert molekyl
DE60019334D1 (de) Antivirale arznei
TNSN07289A1 (en) Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
FI942153A (fi) Tahdistuslaite sumutuslaitteisiin, joissa on paineistettu annostelupullo
EA200201059A1 (ru) Препараты, содержащие глюкокортикостероидное лекарственное средство, для лечения бронхолегочных заболеваний
DE59914183D1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
ITTO20000896A0 (it) Dispositivo erogatore per la somministrazione transdermica di una sostanza contenente un principio attivo e relativa testina erogatrice.
BR0303347A (pt) Formulações de aerossol contendo ésteres de derivados de 3,17-diidroxi estratieno para deposição pulmonar

Legal Events

Date Code Title Description
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/01/2001, OBSERVADAS AS CONDICOES LEGAIS.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent
B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI NO 52400.115898/2018-48 ORIGEM: 25A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO: 5002419-06.2018.4.02.5101/RJ AUTOR: GLENMARK FARMACEUTICA LTDA REU: INPI-INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL REU: CHIESI FARMACEUTICI S.P.A. DECISAO: ANTE O EXPOSTO, JULGO PROCEDENTE EM PARTE O PEDIDO DA PARTE AUTORA, NOS TERMOS DO ARTIGO 487, INCISO I, DO CPC, PARA DETERMINAR O APOSTILAMENTO DA PI9805993-9, COM A INCORPORACAO DA REINVINDICACAO 7 DE SOLUCAO A REIVINDICACAO 1, E PARA DECLARAR A NULIDADE DA PI0107730-9, POR INEXISTIR ATIVIDADE INVENTIVA.

B16D Grant of patent or certificate of addition of invention cancelled

Free format text: REFERENCIA: RPI 2012 DE 28.07.2009, CONFORME DETERMINACAO JUDICIALPROCESSO NO: 5002419-06.2018.4.02.5101/RJ - ORIGEM: 25A VARA FEDERAL DO RIO DE JANEIRO INPI NO 52400.115898/2018-48